Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
Clinical trial NCT00906880 · COMPLETED
Trial details
- NCT number
- NCT00906880
- Sponsor
- Drugs for Neglected Diseases
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-09-01
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.